Cargando…
Clinical efficacy and safety of hypernormal shortened door to needle time (DNT) plus individualized low-dose alteplase therapy in treating acute ischemic stroke
OBJECTIVE: This study aims to observe the clinical efficacies of hyper-early low-dose alteplase thrombolysis in treating acute ischemic stroke (AIS). METHODS: Two hundred twenty AIS patients were randomly divided into group A (90 cases), group B (90 cases), and group C (40 cases). The National Insti...
Autores principales: | Zheng, Mei, Lei, Hongyan, Cui, Yansen, Yang, Daiqun, Wang, Liquang, Wang, Ziran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017082/ https://www.ncbi.nlm.nih.gov/pubmed/27648019 http://dx.doi.org/10.12669/pjms.324.9518 |
Ejemplares similares
-
Impact of Intravenous Alteplase Door-to-Needle Times on 2-Year Mortality in Patients With Acute Ischemic Stroke
por: Bhatt, Nirav R., et al.
Publicado: (2021) -
Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke
por: Li, Hongfei, et al.
Publicado: (2022) -
Semitopological vector spaces: hypernorms, hyperseminorms, and operators
por: Burgin, Mark
Publicado: (2017) -
Beneficial effects of the 30‐minute door‐to‐needle time standard for alteplase administration
por: Rajan, Suja S., et al.
Publicado: (2021) -
Impact of “Stroke Code”-Rapid Response Team: An Attempt to Improve Intravenous Thrombolysis Rate and to Shorten Door-to-Needle Time in Acute Ischemic Stroke
por: Gurav, Sushma K., et al.
Publicado: (2018)